APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody-drug Conjugates

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Selected research

Market Analysis & Forecast

Global Antibody-drug Conjugates Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchAntibody-drug Conjugates Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody-drug Conjugates Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Antibody-drug Conjugates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody-drug Conjugates Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody-drug Conjugates Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Read the full market overview

This report presents an overview of global market for Antibody-drug Conjugates, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antibody-drug Conjugates, also provides the sales of main regions and countries. Of the upcoming market potential for Antibody-drug Conjugates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody-drug Conjugates sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibody-drug Conjugates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antibody-drug Conjugates sales, projected growth trends, production technology, application and end-user industry.

Antibody-drug Conjugates Segment by Company

ImmunoGen

Seattle Genetics

Roche

Takeda

Antibody-drug Conjugates Segment by Type

Adcetris

Kadcyla

Antibody-drug Conjugates Segment by Application

Breast Cancer

Lymphoma

Antibody-drug Conjugates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody-drug Conjugates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody-drug Conjugates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody-drug Conjugates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antibody-drug Conjugates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antibody-drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody-drug Conjugates sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adcetris Major Manufacturers Table 3. Kadcyla Major Manufacturers Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Breast Cancer Major Manufacturers Table 6. Lymphoma Major Manufacturers Table 7. Antibody-drug Conjugates Industry Trends Table 8. Antibody-drug Conjugates Industry Drivers Table 9. Antibody-drug Conjugates Industry Opportunities and Challenges Table 10. Antibody-drug Conjugates Industry Restraints Table 11. Global Antibody-drug Conjugates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Antibody-drug Conjugates Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Antibody-drug Conjugates Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Antibody-drug Conjugates Revenue Market Share by Region (2021-2026) Table 15. Global Antibody-drug Conjugates Revenue Market Share by Region (2027-2032) Table 16. Global Antibody-drug Conjugates Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 17. Global Antibody-drug Conjugates Sales by Region (2021-2026) & (Kg) Table 18. Global Antibody-drug Conjugates Sales by Region (2027-2032) & (Kg) Table 19. Global Antibody-drug Conjugates Sales Market Share by Region (2021-2026) Table 20. Global Antibody-drug Conjugates Sales Market Share by Region (2027-2032) Table 21. Global Antibody-drug Conjugates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Antibody-drug Conjugates Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2021-2026) Table 25. Global Antibody-drug Conjugates Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 26. Global Antibody-drug Conjugates Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Antibody-drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Antibody-drug Conjugates Manufacturers, Product Type & Application Table 29. Global Antibody-drug Conjugates Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Antibody-drug Conjugates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Antibody-drug Conjugates Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2026) Table 36. Global Antibody-drug Conjugates Revenue Market Share by Type (2027-2032) Table 37. Global Antibody-drug Conjugates Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 38. Global Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 39. Global Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 40. Global Antibody-drug Conjugates Sales Market Share by Type (2021-2026) Table 41. Global Antibody-drug Conjugates Sales Market Share by Type (2027-2032) Table 42. Global Antibody-drug Conjugates Price by Type (2021-2026) & (USD/Kg) Table 43. Global Antibody-drug Conjugates Price by Type (2027-2032) & (USD/Kg) Table 44. Global Antibody-drug Conjugates Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2026) Table 48. Global Antibody-drug Conjugates Revenue Market Share by Application (2027-2032) Table 49. Global Antibody-drug Conjugates Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 50. Global Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 51. Global Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 52. Global Antibody-drug Conjugates Sales Market Share by Application (2021-2026) Table 53. Global Antibody-drug Conjugates Sales Market Share by Application (2027-2032) Table 54. Global Antibody-drug Conjugates Price by Application (2021-2026) & (USD/Kg) Table 55. Global Antibody-drug Conjugates Price by Application (2027-2032) & (USD/Kg) Table 56. ImmunoGen Company Information Table 57. ImmunoGen Business Overview Table 58. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 59. ImmunoGen Antibody-drug Conjugates Product Portfolio Table 60. ImmunoGen Recent Development Table 61. Seattle Genetics Company Information Table 62. Seattle Genetics Business Overview Table 63. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 64. Seattle Genetics Antibody-drug Conjugates Product Portfolio Table 65. Seattle Genetics Recent Development Table 66. Roche Company Information Table 67. Roche Business Overview Table 68. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 69. Roche Antibody-drug Conjugates Product Portfolio Table 70. Roche Recent Development Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Takeda Antibody-drug Conjugates Product Portfolio Table 75. Takeda Recent Development Table 76. North America Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 79. North America Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 80. North America Antibody-drug Conjugates Sales Price by Type (2021-2026) & (USD/Kg) Table 81. North America Antibody-drug Conjugates Sales Price by Type (2027-2032) & (USD/Kg) Table 82. North America Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 85. North America Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 86. North America Antibody-drug Conjugates Sales Price by Application (2021-2026) & (USD/Kg) Table 87. North America Antibody-drug Conjugates Sales Price by Application (2027-2032) & (USD/Kg) Table 88. North America Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Antibody-drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Antibody-drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 92. North America Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 93. North America Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 94. North America Antibody-drug Conjugates Sales Price by Country (2021-2026) & (USD/Kg) Table 95. North America Antibody-drug Conjugates Sales Price by Country (2027-2032) & (USD/Kg) Table 96. United States Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 97. Canada Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 98. Mexico Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 99. Europe Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 102. Europe Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 103. Europe Antibody-drug Conjugates Sales Price by Type (2021-2026) & (USD/Kg) Table 104. Europe Antibody-drug Conjugates Sales Price by Type (2027-2032) & (USD/Kg) Table 105. Europe Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 108. Europe Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 109. Europe Antibody-drug Conjugates Sales Price by Application (2021-2026) & (USD/Kg) Table 110. Europe Antibody-drug Conjugates Sales Price by Application (2027-2032) & (USD/Kg) Table 111. Europe Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Antibody-drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Antibody-drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 115. Europe Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 116. Europe Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 117. Europe Antibody-drug Conjugates Sales Price by Country (2021-2026) & (USD/Kg) Table 118. Europe Antibody-drug Conjugates Sales Price by Country (2027-2032) & (USD/Kg) Table 119. Germany Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 120. France Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 121. U.K. Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 122. Italy Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 123. Russia Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 124. Spain Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 125. Netherlands Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 126. Switzerland Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 127. Sweden Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 128. Poland Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 129. China Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 130. China Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 131. China Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 132. China Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 133. China Antibody-drug Conjugates Sales Price by Type (2021-2026) & (USD/Kg) Table 134. China Antibody-drug Conjugates Sales Price by Type (2027-2032) & (USD/Kg) Table 135. China Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 136. China Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 137. China Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 138. China Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 139. China Antibody-drug Conjugates Sales Price by Application (2021-2026) & (USD/Kg) Table 140. China Antibody-drug Conjugates Sales Price by Application (2027-2032) & (USD/Kg) Table 141. Asia Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 144. Asia Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 145. Asia Antibody-drug Conjugates Sales Price by Type (2021-2026) & (USD/Kg) Table 146. Asia Antibody-drug Conjugates Sales Price by Type (2027-2032) & (USD/Kg) Table 147. Asia Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 150. Asia Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 151. Asia Antibody-drug Conjugates Sales Price by Application (2021-2026) & (USD/Kg) Table 152. Asia Antibody-drug Conjugates Sales Price by Application (2027-2032) & (USD/Kg) Table 153. Asia Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Antibody-drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Antibody-drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 157. Asia Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 158. Asia Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 159. Asia Antibody-drug Conjugates Sales Price by Country (2021-2026) & (USD/Kg) Table 160. Asia Antibody-drug Conjugates Sales Price by Country (2027-2032) & (USD/Kg) Table 161. Japan Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 162. South Korea Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 163. India Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 164. Australia Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 165. Taiwan Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Antibody-drug Conjugates Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Antibody-drug Conjugates Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Antibody-drug Conjugates Sales by Type (2021-2026) & (Kg) Table 170. SAMEA Antibody-drug Conjugates Sales by Type (2027-2032) & (Kg) Table 171. SAMEA Antibody-drug Conjugates Sales Price by Type (2021-2026) & (USD/Kg) Table 172. SAMEA Antibody-drug Conjugates Sales Price by Type (2027-2032) & (USD/Kg) Table 173. SAMEA Antibody-drug Conjugates Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Antibody-drug Conjugates Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Antibody-drug Conjugates Sales by Application (2021-2026) & (Kg) Table 176. SAMEA Antibody-drug Conjugates Sales by Application (2027-2032) & (Kg) Table 177. SAMEA Antibody-drug Conjugates Sales Price by Application (2021-2026) & (USD/Kg) Table 178. SAMEA Antibody-drug Conjugates Sales Price by Application (2027-2032) & (USD/Kg) Table 179. SAMEA Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Antibody-drug Conjugates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Antibody-drug Conjugates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 183. SAMEA Antibody-drug Conjugates Sales by Country (2021-2026) & (Kg) Table 184. SAMEA Antibody-drug Conjugates Sales by Country (2027-2032) & (Kg) Table 185. SAMEA Antibody-drug Conjugates Sales Price by Country (2021-2026) & (USD/Kg) Table 186. SAMEA Antibody-drug Conjugates Sales Price by Country (2027-2032) & (USD/Kg) Table 187. Brazil Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 188. Argentina Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 189. Chile Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 190. Colombia Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 191. Peru Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 193. Israel Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 194. UAE Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 195. Turkey Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 196. Iran Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 197. Egypt Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Antibody-drug Conjugates Distributors List Table 201. Antibody-drug Conjugates Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Antibody-drug Conjugates Image Figure 2. Global Antibody-drug Conjugates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody-drug Conjugates Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adcetris Image Figure 5. Kadcyla Image Figure 6. Global Antibody-drug Conjugates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antibody-drug Conjugates Market Size Share 2021 VS 2025 VS 2032 Figure 8. Breast Cancer Image Figure 9. Lymphoma Image Figure 10. Global Antibody-drug Conjugates Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Antibody-drug Conjugates Revenue (2021-2032) & (US$ Million) Figure 12. Global Antibody-drug Conjugates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Antibody-drug Conjugates Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Antibody-drug Conjugates Revenue Market Share by Region (2021-2032) Figure 15. Global Antibody-drug Conjugates Sales (2021-2032) & (Kg) Figure 16. Global Antibody-drug Conjugates Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 17. Global Antibody-drug Conjugates Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Antibody-drug Conjugates Sales YoY (2021-2032) & (Kg) Figure 19. Europe Antibody-drug Conjugates Sales YoY (2021-2032) & (Kg) Figure 20. China Antibody-drug Conjugates Sales YoY (2021-2032) & (Kg) Figure 21. Asia (Excluding China) Antibody-drug Conjugates Sales YoY (2021-2032) & (Kg) Figure 22. South America, Middle East and Africa Antibody-drug Conjugates Sales YoY (2021-2032) & (Kg) Figure 23. Global Antibody-drug Conjugates Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Antibody-drug Conjugates Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Antibody-drug Conjugates Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Antibody-drug Conjugates Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2032) Figure 29. Global Antibody-drug Conjugates Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 30. Global Antibody-drug Conjugates Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Antibody-drug Conjugates Sales Market Share by Type (2021-2032) Figure 32. Global Antibody-drug Conjugates Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Antibody-drug Conjugates Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2032) Figure 35. Global Antibody-drug Conjugates Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 36. Global Antibody-drug Conjugates Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Antibody-drug Conjugates Sales Market Share by Application (2021-2032) Figure 38. North America Antibody-drug Conjugates Revenue Share by Type (2021-2032) Figure 39. North America Antibody-drug Conjugates Sales Share by Type (2021-2032) Figure 40. North America Antibody-drug Conjugates Revenue Share by Application (2021-2032) Figure 41. North America Antibody-drug Conjugates Sales Share by Application (2021-2032) Figure 42. North America Antibody-drug Conjugates Revenue Share by Country (2021-2032) Figure 43. North America Antibody-drug Conjugates Sales Share by Country (2021-2032) Figure 44. Europe Antibody-drug Conjugates Revenue Share by Type (2021-2032) Figure 45. Europe Antibody-drug Conjugates Sales Share by Type (2021-2032) Figure 46. Europe Antibody-drug Conjugates Revenue Share by Application (2021-2032) Figure 47. Europe Antibody-drug Conjugates Sales Share by Application (2021-2032) Figure 48. Europe Antibody-drug Conjugates Revenue Share by Country (2021-2032) Figure 49. Europe Antibody-drug Conjugates Sales Share by Country (2021-2032) Figure 50. China Antibody-drug Conjugates Revenue Share by Type (2021-2032) Figure 51. China Antibody-drug Conjugates Sales Share by Type (2021-2032) Figure 52. China Antibody-drug Conjugates Revenue Share by Application (2021-2032) Figure 53. China Antibody-drug Conjugates Sales Share by Application (2021-2032) Figure 54. Asia Antibody-drug Conjugates Revenue Share by Type (2021-2032) Figure 55. Asia Antibody-drug Conjugates Sales Share by Type (2021-2032) Figure 56. Asia Antibody-drug Conjugates Revenue Share by Application (2021-2032) Figure 57. Asia Antibody-drug Conjugates Sales Share by Application (2021-2032) Figure 58. Asia Antibody-drug Conjugates Revenue Share by Country (2021-2032) Figure 59. Asia Antibody-drug Conjugates Sales Share by Country (2021-2032) Figure 60. SAMEA Antibody-drug Conjugates Revenue Share by Type (2021-2032) Figure 61. SAMEA Antibody-drug Conjugates Sales Share by Type (2021-2032) Figure 62. SAMEA Antibody-drug Conjugates Revenue Share by Application (2021-2032) Figure 63. SAMEA Antibody-drug Conjugates Sales Share by Application (2021-2032) Figure 64. SAMEA Antibody-drug Conjugates Revenue Share by Country (2021-2032) Figure 65. SAMEA Antibody-drug Conjugates Sales Share by Country (2021-2032) Figure 66. Antibody-drug Conjugates Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Antibody-drug Conjugates Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Adcetris
  • Kadcyla
Applications
  • Breast Cancer
  • Lymphoma
Companies covered
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antibody-drug Conjugates Market by Type
  3. 1.2.1 Global Antibody-drug Conjugates Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adcetris
  5. 1.2.3 Kadcyla
  6. 1.3 Antibody-drug Conjugates Market by Application
  7. 1.3.1 Global Antibody-drug Conjugates Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Breast Cancer
  9. 1.3.3 Lymphoma
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Antibody-drug Conjugates Market Dynamics
  1. 2.1 Antibody-drug Conjugates Industry Trends
  2. 2.2 Antibody-drug Conjugates Industry Drivers
  3. 2.3 Antibody-drug Conjugates Industry Opportunities and Challenges
  4. 2.4 Antibody-drug Conjugates Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antibody-drug Conjugates Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antibody-drug Conjugates Revenue by Region
  3. 3.2.1 Global Antibody-drug Conjugates Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antibody-drug Conjugates Revenue by Region (2021-2026)
  5. 3.2.3 Global Antibody-drug Conjugates Revenue by Region (2027-2032)
  6. 3.2.4 Global Antibody-drug Conjugates Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antibody-drug Conjugates Sales by Region
  9. 3.4.1 Global Antibody-drug Conjugates Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antibody-drug Conjugates Sales by Region (2021-2026)
  11. 3.4.3 Global Antibody-drug Conjugates Sales by Region (2027-2032)
  12. 3.4.4 Global Antibody-drug Conjugates Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antibody-drug Conjugates Revenue by Manufacturers
  2. 4.1.1 Global Antibody-drug Conjugates Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antibody-drug Conjugates Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antibody-drug Conjugates Sales by Manufacturers
  6. 4.2.1 Global Antibody-drug Conjugates Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antibody-drug Conjugates Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antibody-drug Conjugates Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antibody-drug Conjugates Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antibody-drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antibody-drug Conjugates Manufacturers, Product Type & Application
  13. 4.7 Global Antibody-drug Conjugates Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antibody-drug Conjugates Market CR5 and HHI
  16. 4.8.2 2025 Antibody-drug Conjugates Tier 1, Tier 2, and Tier 3
5 Antibody-drug Conjugates Market by Type
  1. 5.1 Global Antibody-drug Conjugates Revenue by Type
  2. 5.1.1 Global Antibody-drug Conjugates Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antibody-drug Conjugates Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antibody-drug Conjugates Sales by Type
  6. 5.2.1 Global Antibody-drug Conjugates Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antibody-drug Conjugates Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Antibody-drug Conjugates Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antibody-drug Conjugates Price by Type
6 Antibody-drug Conjugates Market by Application
  1. 6.1 Global Antibody-drug Conjugates Revenue by Application
  2. 6.1.1 Global Antibody-drug Conjugates Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antibody-drug Conjugates Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antibody-drug Conjugates Sales by Application
  6. 6.2.1 Global Antibody-drug Conjugates Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antibody-drug Conjugates Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Antibody-drug Conjugates Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antibody-drug Conjugates Price by Application
7 Company Profiles
  1. 7.1 ImmunoGen
  2. 7.1.1 ImmunoGen Company Information
  3. 7.1.2 ImmunoGen Business Overview
  4. 7.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
  6. 7.1.5 ImmunoGen Recent Developments
  7. 7.2 Seattle Genetics
  8. 7.2.1 Seattle Genetics Company Information
  9. 7.2.2 Seattle Genetics Business Overview
  10. 7.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
  12. 7.2.5 Seattle Genetics Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Roche Antibody-drug Conjugates Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Takeda
  20. 7.4.1 Takeda Company Information
  21. 7.4.2 Takeda Business Overview
  22. 7.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Takeda Antibody-drug Conjugates Product Portfolio
  24. 7.4.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Antibody-drug Conjugates Market Size by Type
  2. 8.1.1 North America Antibody-drug Conjugates Revenue by Type (2021-2032)
  3. 8.1.2 North America Antibody-drug Conjugates Sales by Type (2021-2032)
  4. 8.1.3 North America Antibody-drug Conjugates Price by Type (2021-2032)
  5. 8.2 North America Antibody-drug Conjugates Market Size by Application
  6. 8.2.1 North America Antibody-drug Conjugates Revenue by Application (2021-2032)
  7. 8.2.2 North America Antibody-drug Conjugates Sales by Application (2021-2032)
  8. 8.2.3 North America Antibody-drug Conjugates Price by Application (2021-2032)
  9. 8.3 North America Antibody-drug Conjugates Market Size by Country
  10. 8.3.1 North America Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antibody-drug Conjugates Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antibody-drug Conjugates Market Size by Type
  2. 9.1.1 Europe Antibody-drug Conjugates Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antibody-drug Conjugates Sales by Type (2021-2032)
  4. 9.1.3 Europe Antibody-drug Conjugates Price by Type (2021-2032)
  5. 9.2 Europe Antibody-drug Conjugates Market Size by Application
  6. 9.2.1 Europe Antibody-drug Conjugates Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antibody-drug Conjugates Sales by Application (2021-2032)
  8. 9.2.3 Europe Antibody-drug Conjugates Price by Application (2021-2032)
  9. 9.3 Europe Antibody-drug Conjugates Market Size by Country
  10. 9.3.1 Europe Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antibody-drug Conjugates Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antibody-drug Conjugates Market Size by Type
  2. 10.1.1 China Antibody-drug Conjugates Revenue by Type (2021-2032)
  3. 10.1.2 China Antibody-drug Conjugates Sales by Type (2021-2032)
  4. 10.1.3 China Antibody-drug Conjugates Price by Type (2021-2032)
  5. 10.2 China Antibody-drug Conjugates Market Size by Application
  6. 10.2.1 China Antibody-drug Conjugates Revenue by Application (2021-2032)
  7. 10.2.2 China Antibody-drug Conjugates Sales by Application (2021-2032)
  8. 10.2.3 China Antibody-drug Conjugates Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antibody-drug Conjugates Market Size by Type
  2. 11.1.1 Asia Antibody-drug Conjugates Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antibody-drug Conjugates Sales by Type (2021-2032)
  4. 11.1.3 Asia Antibody-drug Conjugates Price by Type (2021-2032)
  5. 11.2 Asia Antibody-drug Conjugates Market Size by Application
  6. 11.2.1 Asia Antibody-drug Conjugates Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antibody-drug Conjugates Sales by Application (2021-2032)
  8. 11.2.3 Asia Antibody-drug Conjugates Price by Application (2021-2032)
  9. 11.3 Asia Antibody-drug Conjugates Market Size by Country
  10. 11.3.1 Asia Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antibody-drug Conjugates Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antibody-drug Conjugates Market Size by Type
  2. 12.1.1 SAMEA Antibody-drug Conjugates Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antibody-drug Conjugates Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antibody-drug Conjugates Price by Type (2021-2032)
  5. 12.2 SAMEA Antibody-drug Conjugates Market Size by Application
  6. 12.2.1 SAMEA Antibody-drug Conjugates Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antibody-drug Conjugates Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antibody-drug Conjugates Price by Application (2021-2032)
  9. 12.3 SAMEA Antibody-drug Conjugates Market Size by Country
  10. 12.3.1 SAMEA Antibody-drug Conjugates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antibody-drug Conjugates Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antibody-drug Conjugates Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antibody-drug Conjugates Value Chain Analysis
  2. 13.1.1 Antibody-drug Conjugates Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antibody-drug Conjugates Production Mode & Process
  6. 13.2 Antibody-drug Conjugates Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antibody-drug Conjugates Distributors
  9. 13.2.3 Antibody-drug Conjugates Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst